The Determination of the Minimum Safe Level of Interleukin 10IL—10 in (8)
[22] Jankovic， D.， M. C. Kullberg， C. G. Feng， R. S. Goldszmid， C. M. Collazo， et al. "Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protectiveregulatory IL-10 during intracellular protozoan infection." 2007. Journal Expanding Medicine204： 273–283
[23] Anderson， C. F.， M. Oukka， V. J. Kuchroo， and D. Sacks. "CD4(+)CD25(-) Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis." 2007. Journal Expanding Medicine204： 285–297.
[24] Freitas do Rosa′rio， A. P.， T. Lamb， P. Spence， R. Stephens， A. Lang， A. Roers， W. Muller， A. O’Garra， and J. Langhorne. "IL-27 promotes IL-10 production by effector Th1 CD4+ T cells： a critical mechanism for protection from severe immunopathology during malaria infection." 2012.Journal of Immunology. 188： 1178–1190.
[25] Lúcia Moreira-Teixeira， Paul S. Redford， Evangelos Stavropoulos， Nico Ghilardi， Craig L. Maynard， Casey T. Weaver， Ana Paula Freitas do Rosário， Xuemei Wu， Jean Langhorne and Anne O’Garra(July 15， 2017)"T Cell–Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosisInfection".Journal of Immunology， 199 (2) 613-623； DOI： https：//doi.org/10.4049/jimmunol.1601340 .
[26] Ni G1， Liao Z， Chen S， Wang T， Yuan J， Pan X， Mounsey 3， Cavezza S， Liu X，Wei MQ(August 15， 2017)" Blocking IL-10 signalling at the time of immunization does not increase unwanted side effects in mice."BMC Immunology18(1)：40. doi： 10.1186/s12865-017-0224-x.PMID：28810829, 百拇医药(ChangTai. Li)
[23] Anderson， C. F.， M. Oukka， V. J. Kuchroo， and D. Sacks. "CD4(+)CD25(-) Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis." 2007. Journal Expanding Medicine204： 285–297.
[24] Freitas do Rosa′rio， A. P.， T. Lamb， P. Spence， R. Stephens， A. Lang， A. Roers， W. Muller， A. O’Garra， and J. Langhorne. "IL-27 promotes IL-10 production by effector Th1 CD4+ T cells： a critical mechanism for protection from severe immunopathology during malaria infection." 2012.Journal of Immunology. 188： 1178–1190.
[25] Lúcia Moreira-Teixeira， Paul S. Redford， Evangelos Stavropoulos， Nico Ghilardi， Craig L. Maynard， Casey T. Weaver， Ana Paula Freitas do Rosário， Xuemei Wu， Jean Langhorne and Anne O’Garra(July 15， 2017)"T Cell–Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosisInfection".Journal of Immunology， 199 (2) 613-623； DOI： https：//doi.org/10.4049/jimmunol.1601340 .
[26] Ni G1， Liao Z， Chen S， Wang T， Yuan J， Pan X， Mounsey 3， Cavezza S， Liu X，Wei MQ(August 15， 2017)" Blocking IL-10 signalling at the time of immunization does not increase unwanted side effects in mice."BMC Immunology18(1)：40. doi： 10.1186/s12865-017-0224-x.PMID：28810829, 百拇医药(ChangTai. Li)